Seres Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 08/14/2026 | 1.16 M | $9.12 M | 0.00% | 11.98% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 287.78 K | $2.27 M | -2.16% | 2.98% |
| MARSHALL WACE, LLP | 08/13/2026 | 172.25 K | $1.36 M | 23.44% | 1.79% |
| VONTOBEL HOLDING LTD. | 08/03/2026 | 122.98 K | $970.27 K | -11.19% | 1.28% |
| BLACKROCK, INC. | 08/07/2026 | 111.00 K | $875.79 K | 8.80% | 1.15% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 79.97 K | $631.30 K | 6.87% | 0.83% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 63.80 K | $503.38 K | -1.69% | 0.66% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 58.33 K | $460.21 K | -44.63% | 0.60% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 48.69 K | $384.13 K | 22.81% | 0.50% |
| CITADEL ADVISORS LLC | 09/02/2026 | 43.50 K | $343.22 K | -26.89% | 0.45% |
| STATE STREET CORP | 08/07/2026 | 33.90 K | $267.48 K | 0.00% | 0.35% |
| LION POINT CAPITAL, LP | 08/14/2026 | 31.57 K | $249.09 K | 0.00% | 0.33% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 31.05 K | $244.98 K | -1.84% | 0.32% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 31.05 K | $244.98 K | 100.00% | 0.32% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 28.31 K | $223.39 K | -54.57% | 0.29% |
| XTX TOPCO LTD | 08/14/2026 | 20.73 K | $163.58 K | 100.00% | 0.22% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 15.23 K | $120.16 K | 100.00% | 0.16% |
| NORTHERN TRUST CORP | 08/13/2026 | 14.77 K | $116.50 K | 0.00% | 0.15% |
| INVESCO LTD. | 08/14/2026 | 12.97 K | $102.37 K | -10.81% | 0.13% |
| MORGAN STANLEY | 08/13/2026 | 12.14 K | $95.77 K | -44.06% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 11.10 K | $87.58 K | -80.42% | 0.12% |
| CITADEL ADVISORS LLC | 09/02/2026 | 10.50 K | $82.88 K | 100.00% | 0.11% |
| SIMPLEX TRADING, LLC | 08/12/2026 | 4.60 K | $36.28 K | 49.77% | 0.05% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 4.18 K | $33.00 K | 20.10% | 0.04% |
| INTEGRATED WEALTH CONCEPTS LLC | 08/12/2026 | 4.00 K | $31.56 K | 100.00% | 0.04% |
| GROUP ONE TRADING, L.P. | 08/14/2026 | 3.71 K | $29.30 K | 350.73% | 0.04% |
| JPMORGAN CHASE & CO | 08/12/2026 | 3.64 K | $28.33 K | 100.00% | 0.04% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 1.98 K | $15.58 K | 0.00% | 0.02% |
| FMR LLC | 08/13/2026 | 1.53 K | $12.06 K | -12.79% | 0.02% |
| RACHOR INVESTMENT ADVISORY SERVICES, LLC | 07/16/2026 | 1.48 K | $11.65 K | 0.00% | 0.02% |
| UBS GROUP AG | 08/13/2026 | 484 | $3.82 K | -93.12% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 316 | $2.49 K | -60.20% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 211 | $1.67 K | 0.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 167 | $1.32 K | -97.43% | 0.00% |
| CONTINUUM ADVISORY, LLC | 08/06/2026 | 47 | $371 | 100.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 37 | $292 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 10 | $79 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 8 | $63 | 0.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 08/14/2026 | 5 | $39 | 100.00% | 0.00% |
| WHITTIER TRUST CO OF NEVADA INC | 07/28/2026 | 1 | $8 | 100.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 08/10/2026 | 0 | $0 | -100.00% | 0.00% |
| SOUND INCOME STRATEGIES, LLC | 07/20/2026 | 0 | $0 | -100.00% | 0.00% |
| PHYSICIAN WEALTH ADVISORS, INC. | 07/20/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Seres Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 77 institutional investors and hedge funds held shares of Seres Therapeutics Inc. The most heavily invested institutionals were:
Flagship Pioneering Inc.: 1.16 M
VANGUARD CAPITAL MANAGEMENT LLC: 287,776
MARSHALL WACE, LLP: 172,245
Vontobel Holding Ltd.: 122,975
BlackRock, Inc.: 111,000
GEODE CAPITAL MANAGEMENT, LLC: 79,974
23.90% of Seres Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 33.91 M shares in the last 24 months. This purchase volume represents approximately $316.08 M in transactions.